Comparative Effectiveness of Macrolides and Quinolones for Patients Hospitalized With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)

被引:26
|
作者
Rothberg, Michael B. [1 ,2 ,3 ]
Pekow, Penelope S. [3 ,4 ]
Lahti, Maureen [4 ]
Brody, Oren [1 ,2 ]
Skiest, Daniel J. [2 ,5 ]
Lindenauer, Peter K. [2 ,3 ]
机构
[1] Baystate Med Ctr, Dept Med, Div Gen Med, Springfield, MA 01199 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
[3] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA
[4] Univ Massachusetts, Sch Publ Hlth, Amherst, MA 01003 USA
[5] Baystate Med Ctr, Dept Med, Div Infect Dis, Springfield, MA 01199 USA
关键词
antibiotics; chronic obstructive; pulmonary disease; effectiveness; treatment; CLOSTRIDIUM-DIFFICILE; CHRONIC-BRONCHITIS; PROPENSITY SCORE; SHORT-TERM; MANAGEMENT; MORTALITY; OUTBREAK; OUTCOMES; COPD; CLARITHROMYCIN;
D O I
10.1002/jhm.628
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Meta-analyses of randomized trials have found that antibiotics are effective in acute exacerbations of chronic obstructive pulmonary disease (AECOPD), but there is insufficient evidence to guide antibiotic selection. Current guidelines offer conflicting recommendations. OBJECTIVE: To compare the effectiveness of macrolides and quinolones for AECOPD DESIGN: Retrospective cohort study using logistic regression, propensity score matching, and grouped treatment models. SETTING: A total of 375 acute care hospitals throughout the United States. PATIENTS: Age >= 40 years and hospitalized for AECOPD. INTERVENTION: Macrolide or quinolone antibiotic begun in the first 2 hospital days. MEASUREMENTS: Treatment failure (defined as the initiation of mechanical ventilation after hospital day 2, inpatient mortality, or readmission for AECOPD within 30 days), length of stay, and hospital costs. RESULTS: Of the 19,608 patients who met the inclusion criteria, 6139 (31%) were treated initially with a macrolide and 13,469 (69%) with a quinolone. Compared to patients treated initially with a quinolone, those who received macrolides had a lower risk of treatment failure (6.8% vs. 8.1%; P < 0.01), a finding that was attenuated after multivariable adjustment (odds ratio [OR], 0.89; 95% confidence interval [CI], 0.78-1.01), and disappeared in a grouped-treatment analysis (OR, 1.01; 95% CI, 0.75-1.35). There were no differences in adjusted length of stay (ratio, 0.98; 95% CI, 0.97-1.00) or adjusted cost (ratio, 1.00; 95% CI, 0.99-1.02). After propensity score matching, antibiotic-associated diarrhea was more common with quinolones (1.2% vs. 0.6%; P < 0.001). CONCLUSIONS: Macrolide and quinolone antibiotics are associated with similar rates of treatment failure in AECOPD; however, macrolides are less frequently associated with diarrhea. Journal of Hospital Medicine 2010;5:261-267. (C) 2010 Society of Hospital Medicine.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 50 条
  • [1] Evaluation of the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients
    Kumar, Jessica
    Sy, Isabelle
    Wei, Felix
    de Lemos, Jane
    Loh, Gabriel
    Harbin, Megan
    Dahri, Karen
    JOURNAL OF PHARMACY TECHNOLOGY, 2020, 36 (05) : 187 - 195
  • [2] Quality of Care for Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    Chokkara, S.
    Press, V. G.
    Zhu, M.
    Lindenauer, P. K.
    Rojas, J. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [3] Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease
    Lindenauer, Peter K.
    Pekow, Penelope
    Gao, Shan
    Crawford, Allison S.
    Gutierrez, Benjamin
    Benjamin, Evan M.
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) : 894 - 903
  • [4] Costs of the Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in a University Hospital
    Yildirim, Fatma
    Turk, Murat
    Ozturk, Can
    EURASIAN JOURNAL OF PULMONOLOGY, 2015, 17 (03) : 171 - 175
  • [5] Effectiveness of antibiotics in acute exacerbations of chronic obstructive pulmonary disease
    Rothberg, M.
    Brody, O.
    Penelope, P.
    Lahti, M.
    Lindenauer, P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 296 - 296
  • [6] Effectiveness of antibiotics in acute exacerbations of chronic obstructive pulmonary disease
    Abrams, T. E.
    Sarrazin, M. V.
    Rosenthal, G. E.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 296 - 297
  • [7] AECOPD: Acute Exacerbations of Chronic Obstructive Cardiopulmonary Disease?
    Bhatt, Surya P.
    Dransfield, Mark T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (09) : 1046 - 1048
  • [8] Remote Monitoring for Prediction and Management of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD)
    Pepin, Jean-Louis
    Degano, Bruno
    Tamisier, Renaud
    Viglino, Damien
    LIFE-BASEL, 2022, 12 (04):
  • [9] Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
    Sprooten, R. T. M.
    Slenter, R. H. J.
    Kotz, D.
    Wesseling, G.
    Wouters, E. F. M.
    Rohde, G. G. U.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [10] The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
    Coad, Anna
    Bennett, Ruth
    Manuel, Ari
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42